Establishment Labs Holdings Debt to Equity Ratio 2017-2024 | ESTA

Current and historical debt to equity ratio values for Establishment Labs Holdings (ESTA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Establishment Labs Holdings debt/equity for the three months ending March 31, 2024 was 3.38.
Establishment Labs Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.25B $0.06B 4.30
2023-12-31 $0.25B $0.02B 13.60
2023-09-30 $0.24B $0.03B 7.87
2023-06-30 $0.23B $0.06B 4.20
2023-03-31 $0.23B $-0.02B -14.09
2022-12-31 $0.22B $-0.01B -26.79
2022-09-30 $0.19B $0.00B 122.54
2022-06-30 $0.18B $0.02B 11.60
2022-03-31 $0.09B $0.05B 1.96
2021-12-31 $0.09B $0.05B 1.75
2021-09-30 $0.09B $0.06B 1.41
2021-06-30 $0.08B $0.07B 1.21
2021-03-31 $0.08B $0.07B 1.10
2020-12-31 $0.08B $0.08B 1.09
2020-09-30 $0.08B $0.08B 0.94
2020-06-30 $0.08B $0.08B 0.92
2020-03-31 $0.08B $0.09B 0.87
2019-12-31 $0.08B $0.04B 1.94
2019-09-30 $0.07B $0.04B 1.70
2019-06-30 $0.05B $0.05B 0.95
2019-03-31 $0.05B $0.06B 0.79
2018-12-31 $0.05B $0.07B 0.68
2018-09-30 $0.04B $0.08B 0.58
2018-06-30 $0.06B $0.00B 25.71
2018-03-31 $0.07B $-0.01B -7.74
2017-12-31 $0.06B $-0.01B -12.39
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.06B $-0.03B -2.12
Sector Industry Market Cap Revenue
Medical Medical Services $1.321B $0.165B
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $116.504B 14.20
Cencora (COR) United States $44.729B 17.44
ICON (ICLR) Ireland $27.407B 25.88
DiDi Global (DIDIY) China $17.692B 0.00
CochLear (CHEOY) Australia $14.645B 0.00
Avantor (AVTR) United States $14.380B 21.17
Viatris (VTRS) United States $13.693B 4.09
Revvity (RVTY) United States $13.578B 23.82
Natera (NTRA) United States $13.081B 0.00
Charles River Laboratories (CRL) United States $11.347B 21.72
Medpace Holdings (MEDP) United States $11.070B 33.61
EUROFINS SCIENT (ERFSF) Luxembourg $9.854B 0.00
Solventum (SOLV) United States $9.782B 0.00
Sonic Healthcare (SKHHY) Australia $8.268B 0.00
HealthEquity (HQY) United States $6.856B 44.02
Bausch + Lomb (BLCO) Canada $5.992B 23.99
Organon (OGN) United States $5.519B 5.23
Doximity (DOCS) United States $5.235B 36.66
PACS (PACS) United States $5.163B 0.00
Life Times (LTH) United States $4.191B 43.92
Sotera Health (SHC) United States $3.773B 18.51
Surgery Partners (SGRY) United States $3.602B 32.95
GoodRx Holdings (GDRX) United States $3.343B 127.29
Agilon Health (AGL) United States $2.904B 0.00
Progyny (PGNY) United States $2.691B 46.33
AMN Healthcare Services Inc (AMN) United States $2.272B 9.00
BrightSpring Health Services (BTSG) United States $2.085B 0.00
Premier (PINC) United States $2.083B 8.91
Alignment Healthcare (ALHC) United States $1.824B 0.00
Teladoc Health (TDOC) United States $1.577B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.467B 0.00
CareDx (CDNA) United States $0.990B 0.00
Embecta (EMBC) United States $0.935B 6.36
GeneDx Holdings (WGS) United States $0.869B 0.00
InnovAge Holding (INNV) United States $0.840B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Auna S.A (AUNA) Luxembourg $0.638B 0.00
Sharecare (SHCR) United States $0.500B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.497B 0.00
Enhabit (EHAB) United States $0.488B 48.65
Sonida Senior Living (SNDA) United States $0.420B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
DocGo (DCGO) United States $0.337B 18.44
ModivCare (MODV) United States $0.337B 6.30
LifeMD (LFMD) United States $0.292B 0.00
MultiPlan (MPLN) United States $0.289B 0.00
Sera Prognostics (SERA) United States $0.260B 0.00
Beauty Health (SKIN) United States $0.230B 0.00
Ascend Wellness Holdings (AAWH) United States $0.206B 0.00
Biodesix (BDSX) United States $0.189B 0.00
So-Young (SY) China $0.098B 47.50
Pono Capital Two (PTWO) United States $0.072B 0.00
NeueHealth (NEUE) United States $0.044B 5.88
Oncology Institute (TOI) United States $0.041B 0.00
Co-Diagnostics (CODX) United States $0.041B 0.00
IceCure Medical (ICCM) Israel $0.038B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
OncoCyte (OCX) United States $0.027B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.018B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.003B 0.00
Assure Holdings (IONM) United States $0.001B 0.00